KEGG_Pathway_down-regualated,Hits,P.Value,,,KEGG_Pathway_up-regulated,Hits,P.Value
Pyrimidine metabolism,19,4.44E-09,,,Pathways in cancer,64,1.50E-17
Insulin signaling pathway,16,7.43E-05,,,Focal adhesion,49,1.46E-16
Oocyte meiosis,14,7.48E-05,,,ErbB signaling pathway,29,7.45E-14
Cell cycle,14,0.000387,,,Glioma,22,8.51E-11
Purine metabolism,16,0.00069,,,Adherens junction,22,4.26E-10
Legionellosis,7,0.00105,,,Neurotrophin signaling pathway,29,1.83E-09
p53 signaling pathway,9,0.00132,,,Non-small cell lung cancer,18,3.29E-09
Long-term potentiation,9,0.00132,,,Regulation of actin cytoskeleton,35,7.26E-09
Regulation of autophagy,3,0.00284,,,Prostate cancer,22,2.88E-08
RNA transport,13,0.00323,,,Type II diabetes mellitus,15,4.44E-07
Autoimmune thyroid disease,3,0.00414,,,Acute myeloid leukemia,16,5.03E-07
Systemic lupus erythematosus,4,0.00552,,,Calcium signaling pathway,30,1.41E-06
Protein processing in endoplasmic reticulum,12,0.00655,,,Pancreatic cancer,17,2.07E-06
Neurotrophin signaling pathway,11,0.00981,,,Colorectal cancer,14,2.08E-06
Pertussis,6,0.0137,,,Axon guidance,23,2.53E-06
Type I diabetes mellitus,2,0.014,,,Insulin signaling pathway,25,2.78E-06
Alcoholism,14,0.0153,,,Bacterial invasion of epithelial cells,15,2.83E-06
SNARE interactions in vesicular transport,4,0.0172,,,Chronic myeloid leukemia,17,4.71E-06
Cytokine-cytokine receptor interaction,16,0.0172,,,Basal cell carcinoma,13,7.22E-06
Influenza A,9,0.0186,,,Long-term potentiation,16,7.92E-06
Amyotrophic lateral sclerosis (ALS),5,0.0187,,,Wnt signaling pathway,25,1.03E-05
Asthma,2,0.0205,,,Endometrial cancer,12,1.91E-05
Herpes simplex infection,9,0.0209,,,Fc gamma R-mediated phagocytosis,18,2.67E-05
Intestinal immune network for IgA production,4,0.025,,,Renal cell carcinoma,14,3.33E-05
Viral myocarditis,4,0.025,,,Tight junction,21,4.41E-05
Ribosome biogenesis in eukaryotes,6,0.0353,,,Circadian rhythm - mammal,8,5.01E-05
Progesterone-mediated oocyte maturation,7,0.0379,,,Cholinergic synapse,18,5.61E-05
Apoptosis,7,0.0401,,,Long-term depression,15,5.88E-05
RIG-I-like receptor signaling pathway,5,0.041,,,Aldosterone-regulated sodium reabsorption,10,8.07E-05
Salmonella infection,6,0.0485,,,Melanogenesis,18,8.52E-05
,,,,,Jak-STAT signaling pathway,18,0.000111
,,,,,Glutamatergic synapse,18,0.000111
,,,,,ECM-receptor interaction,16,0.000122
,,,,,Small cell lung cancer,15,0.000207
,,,,,Endocytosis,17,0.000275
,,,,,Arrhythmogenic right ventricular cardiomyopathy (ARVC),5,0.000683
,,,,,Hedgehog signaling pathway,11,0.000698
,,,,,mTOR signaling pathway,10,0.00071
,,,,,Carbohydrate digestion and absorption,6,0.000782
,,,,,Dopaminergic synapse,19,0.000801
,,,,,Notch signaling pathway,10,0.0012
,,,,,Melanoma,12,0.00176
,,,,,Gap junction,14,0.00183
,,,,,Huntington's disease,7,0.00191
,,,,,MAPK signaling pathway,30,0.00264
,,,,,Pancreatic secretion,7,0.00293
,,,,,Amphetamine addiction,11,0.00298
,,,,,Gastric acid secretion,10,0.00298
,,,,,Dilated cardiomyopathy,12,0.00405
,,,,,Chemokine signaling pathway,22,0.00501
,,,,,GnRH signaling pathway,13,0.00745
,,,,,Thyroid cancer,6,0.00901
,,,,,Fc epsilon RI signaling pathway,11,0.0102
,,,,,T cell receptor signaling pathway,13,0.0125
,,,,,HTLV-I infection,24,0.0126
,,,,,Salivary secretion,8,0.0146
,,,,,Amyotrophic lateral sclerosis (ALS),7,0.0151
,,,,,Progesterone-mediated oocyte maturation,11,0.0176
,,,,,Epstein-Barr virus infection,14,0.0184
,,,,,Synaptic vesicle cycle,4,0.023
,,,,,Phosphatidylinositol signaling system,10,0.0259
,,,,,B cell receptor signaling pathway,10,0.0259
,,,,,VEGF signaling pathway,10,0.0282
,,,,,Morphine addiction,8,0.0306
,,,,,Leukocyte transendothelial migration,13,0.0321
,,,,,Dorso-ventral axis formation,3,0.0324
,,,,,Hepatitis C,12,0.0328
,,,,,Chagas disease (American trypanosomiasis),11,0.0331
,,,,,Bladder cancer,5,0.0458